As UCB marks 10 years in the UK with a special event at its research centre in Slough, Andrew McConaghie talks to chief executive Roch Doliveux about the company's future.

The company’s operation in Slough began life as the UK biotech Celltech, which UCB bought in 2004. Further details will be announced if UCB finalises its search for a suitable location and when ...